The views and opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC/HRS. More

Editor's Choice

Kenneth A. Ellenbogen, MD, FHRS, FACC

Editor-In-Chief | Disclosure

Editor's Choice

Atrial Fibrillation Management Strategies and Early Mortality After Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
 
A Multimarker Approach to Assess the Influence of Inflammation on the Incidence of Atrial Fibrillation in Women
 
Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation. The Impact of Periprocedural Therapeutic International Normalized Ratio
 
Are Atrial Fibrillation Patients Receiving Warfarin in Accordance With Stroke Risk?
 
A New ERA: Evidence-based Stroke and Symptom Reduction in Atrial Fibrillation

News

REALISE-AF Registry: Describing Characteristics, Risk, and Management of AF Patients
 
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes (AVERROES)
 
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications for Thromboprophylaxis

The risk of stroke is markedly decreased after a "successful" AF ablation procedure
 

EP Insights

Ideas and information for heart rhythm professionals from leaders in the field.
More »

Community Login

Username

Password

Forgot your password?

Site Sponsor

Banner
Advertisement
Banner